Cargando…
ZIP4 Is a Novel Cancer Stem Cell Marker in High-Grade Serous Ovarian Cancer
SIMPLE SUMMARY: Ovarian cancer is the most deadly gynecologic cancer. The treatment options for ovarian cancer, and for the recurrent cancer in particular, are limited. One of the major obstacles is the presence of drug-resistant cancer stem cells. The aim of this study is to identify and characteri...
Autores principales: | Fan, Qipeng, Zhang, Wen, Emerson, Robert E., Xu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764492/ https://www.ncbi.nlm.nih.gov/pubmed/33316986 http://dx.doi.org/10.3390/cancers12123692 |
Ejemplares similares
-
A Novel ZIP4-HDAC4-VEGFA Axis in High-Grade Serous Ovarian Cancer
por: Fan, Qipeng, et al.
Publicado: (2021) -
The novel ZIP4 regulation and its role in ovarian cancer
por: Fan, Qipeng, et al.
Publicado: (2017) -
FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer
por: Fan, Qipeng, et al.
Publicado: (2015) -
Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness
por: Wang, Zhihang, et al.
Publicado: (2022) -
Cell Origins of High-Grade Serous Ovarian Cancer
por: Kim, Jaeyeon, et al.
Publicado: (2018)